Navigation Links
Professor Nancy Ip Joins aTyr Pharma's Scientific Advisory Board
Date:8/17/2009

SAN DIEGO, Aug. 17 /PRNewswire/ -- aTyr Pharma announced today that Professor Nancy Ip, Chair Professor of the Department of Biochemistry and Director of the Molecular Neuroscience Center at Hong Kong University of Science and Technology (HKUST), has joined their scientific advisory board. An elected academician of the Chinese Academy of Sciences and recipient of China's highest honor in the natural sciences, the National Natural Sciences award, Prof. Ip is widely respected for her discoveries in neurosciences. Her accomplishments include elucidation of key signaling mechanisms for nerve cells that have resulted in the discovery of potential treatments for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.

aTyr Pharma has discovery candidates for treatment of neurological disorders as well as other indications. These novel, naturally occurring proteins are resectins of tRNA synthetases. According to Jeff Watkins, CEO of aTyr Pharma, "The tRNA synthetases play a fundamental role in protein synthesis, but tRNA synthetases in humans have resected forms ("resectins") which provide additional essential signaling activities. aTyr Pharma has discovered proprietary resectins with neuro-protective activities. Applying Prof. Ip's knowledge and experience in neurosciences will accelerate our understanding and development of aTyr Pharma's novel class of therapeutic proteins, helping us to bring novel treatments for neuronal diseases to the market as quickly as possible."

Professor Paul Schimmel of TSRI and co-founder of aTyr Pharma adds, "Prof. Ip has established a world renowned Center for Molecular Neurosciences at HKUST focused on discovery of new medicines, and we look forward to using her perspectives for understanding the neurobiology of our resectins. In addition to her remarkable discoveries in neuroscience, Prof. Ip brings a passion for promoting science and biotechnology in China and Hong Kong. With Pangu BioPharma, our subsidiary based in Hong Kong, we share Prof. Ip's goal of tapping the scientific talents and resources in China for strategic advantages in the biotechnology arena."

Prof. Ip obtained her Ph. D. in Pharmacology from Harvard Medical School before working as a senior staff scientist of Regeneron Pharmaceuticals, Inc. in New York and ultimately joining HKUST. She has published more than 200 papers with over 13,000 citations by other scientists and holds 18 patents. Editor-in-Chief of NeuroSignals, Prof. Ip also sits on the editorial boards for several international journals including Journal of Neuroscience. Her extensive list of awards includes being the first honoree in life sciences from China for the L'Oreal-UNESCO Women in Science Award, and being awarded the Scientific and Technological Prize of the Ho Leung Ho Lee Foundation. She received an honorary Doctor of Humane Sciences degree from Simmons College, as well as the Leader of the Year award in research and the Medal of Honor from the Hong Kong Government.

About aTyr Pharma

aTyr Pharma, Inc. is a biopharmaceutical company focused on the discovery of an entirely new class of biologics. aTyr Pharma's discovery engine for new biotherapeutics consists of novel proteins in the family of tRNA synthetases with cell signaling activities distinct from the protein synthesis activities commonly associated with the tRNA synthetases. These proteins are being developed as novel therapeutics to treat cancer, neurodegenerative diseases, inflammation, cardiovascular diseases and metabolic disorders.

www.atyrpharma.com


'/>"/>
SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Physics professor lauded for NSF efforts with prestigious award
2. Physics professor lauded for NSF efforts with prestigious award
3. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
4. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
5. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
6. Cambridge Major Appoints Professor John Hartwig as Scientific Advisor
7. Professor Straufs research is Nature Photonics’ cover article
8. Professor Toh-Ming Lu named fellow of the Materials Research Society
9. Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
10. Professor-turned-producer learns the movie biz
11. UCF professor develops vaccine to protect against black plague bioterror attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
(Date:6/23/2016)... PUNE, India , June 23, 2016 /PRNewswire/ ... culture media market research report to its pharmaceuticals ... company profiles, product details and much more. ... market spread across 151 pages, profiling 15 companies ... now available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
(Date:6/22/2016)... , June 22, 2016  According to ... next generation sequencing (NGS) market include significant efforts ... smaller sequencers.  More accessible and affordable sequencers, say ... growing demand for consumables including sample prep materials.  ... Market for Sample Preparation for Next Generation Sequencing ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):